Derma Sciences Inc (DSCI) financial statements (2022 and earlier)

Company profile

Business Address 214 CARNEGIE CENTER, SUITE 300
PRINCETON, NJ 08540
State of Incorp. PA
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:56,92875,39321,98045,845
Cash and cash equivalents15,81419,3976,50241,617
Short-term investments25,00455,99615,4783,730
Other undisclosed cash, cash equivalents, and short-term investments16,110  498
Receivables8,1468,7587,3337,086
Inventory, net of allowances, customer advances and progress billings20,69113,28116,47313,671
Inventory20,69113,28116,47313,671
Prepaid expense and other current assets3,209
Deferred tax assets 728 
Other undisclosed current assets(14,661)3,4043,718(498)
Total current assets:71,104100,84449,53269,312
Noncurrent Assets
Property, plant and equipment4,1293,6142,9533,305
Long-term investments and receivables16,1108,4237,858498
Long-term investments16,1108,4237,858498
Intangible assets, net (including goodwill)23,28926,27328,09430,587
Goodwill13,45813,45813,45813,458
Intangible assets, net (excluding goodwill)9,83112,81614,63617,129
Other noncurrent assets148144139
Prepaid expense and other noncurrent assets141
Total noncurrent assets:43,67638,45439,04534,531
TOTAL ASSETS:114,780139,29888,576103,843
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,5558,4537,0525,923
Accounts payable2,4735,0594,5233,994
Accrued liabilities6,691464  
Employee-related liabilities2,3912,9312,5291,930
Restructuring reserve1,492 
Deferred tax liabilities 1,7011,694 
Other liabilities 1,8671,279823
Other undisclosed current liabilities488(510)(534)1,380
Total current liabilities:13,53511,5119,4928,127
Noncurrent Liabilities
Liabilities, other than long-term debt2,8192,7432,1792,273
Deferred revenue and credits 521242269
Deferred tax liabilities, net1,8051,7011,6941,736
Other liabilities1,014521242269
Other undisclosed noncurrent liabilities (521)(242)(269)
Total noncurrent liabilities:2,8192,2221,9362,005
Total liabilities:16,35413,73311,42810,131
Stockholders' equity
Stockholders' equity attributable to parent, including:98,426125,56577,14893,711
Preferred stock1111
Common stock259253173165
Additional paid in capital234,943228,342140,065132,163
Accumulated other comprehensive income5,2739721,2181,589
Accumulated deficit(142,050)(103,942)(64,171)(40,207)
Other undisclosed stockholders' equity attributable to parent (61)(138) 
Total stockholders' equity:98,426125,56577,14893,711
TOTAL LIABILITIES AND EQUITY:114,780139,29888,576103,843

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
84,47483,74679,71172,648
Cost of revenue
(Cost of Goods and Services Sold)
(51,740)(53,636)(50,328)(49,807)
Other undisclosed gross profit  72,300
Gross profit:32,73430,11029,39025,141
Operating expenses(54,696)(70,214)(53,380)(39,608)
Operating loss:(21,962)(40,104)(23,990)(14,468)
Nonoperating income (expense)(650)18218627
Investment income, nonoperating28922675 
Foreign currency transaction gain (loss), before tax280(408)  
Other nonoperating income   6
Loss from continuing operations before income taxes:(22,611)(39,923)(23,804)(14,441)
Income tax expense (benefit)2,245151(160)2,370
Net loss:(20,367)(39,772)(23,964)(12,070)
Net loss attributable to noncontrolling interest(17,741)   
Net loss available to common stockholders, diluted:(38,107)(39,772)(23,964)(12,070)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(20,367)(39,772)(23,964)(12,070)
Other comprehensive income (loss)4,361(169)(509) 
Comprehensive loss:(16,005)(39,940)(24,473)(12,070)
Comprehensive loss, net of tax, attributable to noncontrolling interest(17,741)   
Other undisclosed comprehensive income, net of tax, attributable to parent   86
Comprehensive loss, net of tax, attributable to parent:(33,746)(39,940)(24,473)(11,984)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: